WACKER, founded in 1914 and headquartered in Germany, is a standout in the chemical and biotechnology sectors, emphasizing innovation and sustainability. Known for the slogan "CREATING TOMORROW'S SOLUTIONS," the company provides a wide array of specialty products, including silicones, polymeric binders, additives, and hyperpure silicon, serving industries from health care to semiconductors.
WACKER's portfolio extends to contract manufacturing services, focusing on process development and GMP production for the biopharmaceutical sector along with precision fermentation. They are recognized as a technology leader, consistently pushing the boundaries in health care, energy efficiency, and environmental protection, all while aiming to create significant value-added potential.
Despite their long-standing market presence, there is no record of recent investments, suggesting an established position rather than an active search for venture funding. Investors might find WACKER's stable industry standing and innovation-focused mindset appealing.